AMREP CORP (AXR) Fundamental Analysis & Valuation

NYSE:AXR • US0321591051

Current stock price

25.9 USD
-1.04 (-3.86%)
At close:
25.95 USD
+0.05 (+0.19%)
After Hours:

This AXR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. AXR Profitability Analysis

1.1 Basic Checks

  • In the past year AXR was profitable.
  • In the past year AXR had a positive cash flow from operations.
  • AXR had positive earnings in each of the past 5 years.
  • In the past 5 years AXR always reported a positive cash flow from operatings.
AXR Yearly Net Income VS EBIT VS OCF VS FCFAXR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M 20M

1.2 Ratios

  • AXR has a Return On Assets of 8.98%. This is amongst the best in the industry. AXR outperforms 96.83% of its industry peers.
  • With an excellent Return On Equity value of 9.28%, AXR belongs to the best of the industry, outperforming 84.13% of the companies in the same industry.
  • With an excellent Return On Invested Capital value of 8.52%, AXR belongs to the best of the industry, outperforming 95.24% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for AXR is above the industry average of 5.74%.
  • The 3 year average ROIC (7.98%) for AXR is below the current ROIC(8.52%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 8.98%
ROE 9.28%
ROIC 8.52%
ROA(3y)11.25%
ROA(5y)11.62%
ROE(3y)11.7%
ROE(5y)12.51%
ROIC(3y)7.98%
ROIC(5y)10.76%
AXR Yearly ROA, ROE, ROICAXR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20

1.3 Margins

  • AXR has a Profit Margin of 24.40%. This is amongst the best in the industry. AXR outperforms 88.89% of its industry peers.
  • AXR's Profit Margin has declined in the last couple of years.
  • AXR has a Operating Margin of 26.06%. This is amongst the best in the industry. AXR outperforms 92.06% of its industry peers.
  • In the last couple of years the Operating Margin of AXR has declined.
  • AXR has a Gross Margin of 42.44%. This is in the better half of the industry: AXR outperforms 69.84% of its industry peers.
  • In the last couple of years the Gross Margin of AXR has grown nicely.
Industry RankSector Rank
OM 26.06%
PM (TTM) 24.4%
GM 42.44%
OM growth 3Y-12.34%
OM growth 5YN/A
PM growth 3Y-1.77%
PM growth 5YN/A
GM growth 3Y-4.88%
GM growth 5Y19.57%
AXR Yearly Profit, Operating, Gross MarginsAXR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. AXR Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so AXR is destroying value.
  • AXR has more shares outstanding than it did 1 year ago.
  • AXR has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for AXR has been reduced compared to a year ago.
AXR Yearly Shares OutstandingAXR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M
AXR Yearly Total Debt VS Total AssetsAXR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

2.2 Solvency

  • AXR has an Altman-Z score of 21.44. This indicates that AXR is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 21.44, AXR belongs to the top of the industry, outperforming 96.83% of the companies in the same industry.
  • AXR has a debt to FCF ratio of 0.00. This is a very positive value and a sign of high solvency as it would only need 0.00 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 0.00, AXR belongs to the top of the industry, outperforming 92.06% of the companies in the same industry.
  • AXR has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.00, AXR belongs to the top of the industry, outperforming 88.89% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 21.44
ROIC/WACC0.94
WACC9.06%
AXR Yearly LT Debt VS Equity VS FCFAXR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

2.3 Liquidity

  • AXR has a Current Ratio of 25.70. This indicates that AXR is financially healthy and has no problem in meeting its short term obligations.
  • AXR's Current ratio of 25.70 is amongst the best of the industry. AXR outperforms 98.41% of its industry peers.
  • A Quick Ratio of 11.00 indicates that AXR has no problem at all paying its short term obligations.
  • AXR has a better Quick ratio (11.00) than 96.83% of its industry peers.
Industry RankSector Rank
Current Ratio 25.7
Quick Ratio 11
AXR Yearly Current Assets VS Current LiabilitesAXR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. AXR Growth Analysis

3.1 Past

  • AXR shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -0.33%.
  • AXR shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 2.33% yearly.
  • The Revenue has decreased by -8.70% in the past year.
  • Measured over the past years, AXR shows a very strong growth in Revenue. The Revenue has been growing by 21.46% on average per year.
EPS 1Y (TTM)-0.33%
EPS 3Y2.33%
EPS 5YN/A
EPS Q2Q%338.11%
Revenue 1Y (TTM)-8.7%
Revenue growth 3Y-5.51%
Revenue growth 5Y21.46%
Sales Q2Q%93.79%

3.2 Future

  • Based on estimates for the next years, AXR will show a small growth in Earnings Per Share. The EPS will grow by 2.71% on average per year.
  • AXR is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.91% yearly.
EPS Next Y-4.9%
EPS Next 2Y-5.59%
EPS Next 3Y-2.55%
EPS Next 5Y2.71%
Revenue Next Year12.43%
Revenue Next 2Y8.39%
Revenue Next 3Y8.21%
Revenue Next 5Y11.91%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
AXR Yearly Revenue VS EstimatesAXR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 20M 40M 60M
AXR Yearly EPS VS EstimatesAXR Yearly EPS VS EstimatesYearly EPS VS Estimates 2026 2027 2028 2029 0.5 1 1.5 2 2.5

More info and screens

Find the best growth stocksShow best growing peers

7

4. AXR Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 10.75, the valuation of AXR can be described as very reasonable.
  • 84.13% of the companies in the same industry are more expensive than AXR, based on the Price/Earnings ratio.
  • Compared to an average S&P500 Price/Earnings ratio of 24.88, AXR is valued rather cheaply.
  • A Price/Forward Earnings ratio of 12.27 indicates a correct valuation of AXR.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of AXR indicates a rather cheap valuation: AXR is cheaper than 93.65% of the companies listed in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 22.19. AXR is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 10.75
Fwd PE 12.27
AXR Price Earnings VS Forward Price EarningsAXR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • AXR's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. AXR is cheaper than 96.83% of the companies in the same industry.
  • 85.71% of the companies in the same industry are more expensive than AXR, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 10.49
EV/EBITDA 6.6
AXR Per share dataAXR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

  • AXR has an outstanding profitability rating, which may justify a higher PE ratio.
  • AXR's earnings are expected to decrease with -2.55% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-5.59%
EPS Next 3Y-2.55%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. AXR Dividend Analysis

5.1 Amount

  • AXR does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

AXR Fundamentals: All Metrics, Ratios and Statistics

AMREP CORP

NYSE:AXR (3/27/2026, 8:04:00 PM)

After market: 25.95 +0.05 (+0.19%)

25.9

-1.04 (-3.86%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)03-12
Earnings (Next)07-23
Inst Owners44.69%
Inst Owner Change-0.97%
Ins Owners45.64%
Ins Owner Change2.08%
Market Cap137.53M
Revenue(TTM)53.00M
Net Income(TTM)12.93M
Analysts80
Price Target23.46 (-9.42%)
Short Float %0.81%
Short Ratio5.06
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-24.87%
Min EPS beat(2)-50.49%
Max EPS beat(2)0.75%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-17.5%
Min Revenue beat(2)-37.84%
Max Revenue beat(2)2.84%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-23.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)19.15%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.45%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-9.31%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-12.55%
Valuation
Industry RankSector Rank
PE 10.75
Fwd PE 12.27
P/S 2.59
P/FCF 10.49
P/OCF 10.08
P/B 0.99
P/tB 0.99
EV/EBITDA 6.6
EPS(TTM)2.41
EY9.31%
EPS(NY)2.11
Fwd EY8.15%
FCF(TTM)2.47
FCFY9.53%
OCF(TTM)2.57
OCFY9.92%
SpS9.98
BVpS26.25
TBVpS26.25
PEG (NY)N/A
PEG (5Y)N/A
Graham Number37.73
Profitability
Industry RankSector Rank
ROA 8.98%
ROE 9.28%
ROCE 9.91%
ROIC 8.52%
ROICexc 13.29%
ROICexgc 13.34%
OM 26.06%
PM (TTM) 24.4%
GM 42.44%
FCFM 24.74%
ROA(3y)11.25%
ROA(5y)11.62%
ROE(3y)11.7%
ROE(5y)12.51%
ROIC(3y)7.98%
ROIC(5y)10.76%
ROICexc(3y)10.52%
ROICexc(5y)13.87%
ROICexgc(3y)10.56%
ROICexgc(5y)13.9%
ROCE(3y)9.27%
ROCE(5y)12.5%
ROICexgc growth 3Y-24.11%
ROICexgc growth 5YN/A
ROICexc growth 3Y-24.15%
ROICexc growth 5YN/A
OM growth 3Y-12.34%
OM growth 5YN/A
PM growth 3Y-1.77%
PM growth 5YN/A
GM growth 3Y-4.88%
GM growth 5Y19.57%
F-Score5
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 179.26%
Cap/Sales 1.01%
Interest Coverage 250
Cash Conversion 96.71%
Profit Quality 101.38%
Current Ratio 25.7
Quick Ratio 11
Altman-Z 21.44
F-Score5
WACC9.06%
ROIC/WACC0.94
Cap/Depr(3y)283.02%
Cap/Depr(5y)282.35%
Cap/Sales(3y)0.78%
Cap/Sales(5y)0.91%
Profit Quality(3y)86%
Profit Quality(5y)103.5%
High Growth Momentum
Growth
EPS 1Y (TTM)-0.33%
EPS 3Y2.33%
EPS 5YN/A
EPS Q2Q%338.11%
EPS Next Y-4.9%
EPS Next 2Y-5.59%
EPS Next 3Y-2.55%
EPS Next 5Y2.71%
Revenue 1Y (TTM)-8.7%
Revenue growth 3Y-5.51%
Revenue growth 5Y21.46%
Sales Q2Q%93.79%
Revenue Next Year12.43%
Revenue Next 2Y8.39%
Revenue Next 3Y8.21%
Revenue Next 5Y11.91%
EBIT growth 1Y4.28%
EBIT growth 3Y-17.16%
EBIT growth 5YN/A
EBIT Next Year19.88%
EBIT Next 3Y1.05%
EBIT Next 5Y6.19%
FCF growth 1Y20.66%
FCF growth 3Y-12.03%
FCF growth 5Y66.27%
OCF growth 1Y22.02%
OCF growth 3Y-12.86%
OCF growth 5Y67.79%

AMREP CORP / AXR Fundamental Analysis FAQ

What is the fundamental rating for AXR stock?

ChartMill assigns a fundamental rating of 7 / 10 to AXR.


What is the valuation status of AMREP CORP (AXR) stock?

ChartMill assigns a valuation rating of 7 / 10 to AMREP CORP (AXR). This can be considered as Undervalued.


How profitable is AMREP CORP (AXR) stock?

AMREP CORP (AXR) has a profitability rating of 8 / 10.


How financially healthy is AMREP CORP?

The financial health rating of AMREP CORP (AXR) is 9 / 10.